Treatment of experimental breast cancer with combination of IL-12 gene therapy and anti-VEGFR-2 antibody

被引：0
|
作者：
Rakhmilevich, AL
Hooper, AT
Imboden, M
Hicklin, DJ
Sondel, PM
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] ImClone Syst Inc, New York, NY USA
来源：
CANCER GENE THERAPY | 2003年 / 10卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
102
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [11] Production of IL-12 from gene modified human dermal fibroblasts: A preclinical study for IL-12 cancer gene therapy
    Park, C
    Kang, WK
    Oh, M
    Kim, WS
    Yang, JH
    Lotze, MT
    Kim, S
    Park, K
    Park, CH
    EXPERIMENTAL AND MOLECULAR MEDICINE, 1997, 29 (01): : 65 - 69
  • [12] Tumor Specific Delivery and Therapy by Double-Targeted Nanostructured Lipid Carriers with Anti-VEGFR-2 Antibody
    Liu, Donghua
    Liu, Fengxi
    Liu, Zhihong
    Wang, Lili
    Zhang, Na
    MOLECULAR PHARMACEUTICS, 2011, 8 (06) : 2291 - 2301
  • [13] The anti-tumour effect of a DNA vaccine carrying a fusion gene of human VEGFR2 and IL-12
    Wen, Sha
    Zhang, Jia
    Zhou, Ping
    Luo, Cheng
    Liu, Yingfu
    Xu, Zhongwei
    Chen, Xiaoyi
    Ma, Houxun
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2016, 30 (05) : 956 - 962
  • [14] Regulated intratumoral expression of IL-12 in combination with cytotoxic agents as a strategy for the treatment of metastatic breast cancer
    Nemunaitis, J.
    McArthur, H.
    Hudis, C.
    Reed, T.
    Broder, S.
    Lebel, F.
    Barrett, J.
    Lewis, J.
    Norton, L.
    CANCER RESEARCH, 2013, 73
  • [15] IL-10 and IL-12 expression in breast cancer patients and effect of therapy
    Rao, V. S.
    Alabi, A.
    Dyer, C. E.
    Greenman, J.
    Drew, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [16] Effects of IL-12 gene therapy on spontaneous transgenic and transplanted breast tumors
    Francesca Faggioli
    Sabina Soldati
    Eugenio Scanziani
    Enrica Mira Catò
    Fulvio Adorni
    Paolo Vezzoni
    Douglas M. Noonan
    Maria Grazia Sacco
    Breast Cancer Research and Treatment, 2008, 110 : 223 - 226
  • [17] Effects of IL-12 gene therapy on spontaneous transgenic and transplanted breast tumors
    Faggioli, Francesca
    Soldati, Sabina
    Scanziani, Eugenio
    Cato, Enrica Mira
    Adorni, Fulvio
    Vezzoni, Paolo
    Noonan, Douglas M.
    Sacco, Maria Grazia
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 110 (02) : 223 - 226
  • [18] Integrated in silico and in vitro exploration of the anti-VEGFR-2 activities of a semisynthetic xanthine alkaloid inhibiting breast cancer
    Elkaeed, Eslam B.
    Elkady, Hazem
    Khattab, Ahmed M.
    Yousef, Reda G.
    Al-ghulikah, Hanan A.
    Husein, Dalal Z.
    Ibrahim, Ibrahim M.
    Elkady, Mohamed A.
    Metwaly, Ahmed M.
    Eissa, Ibrahim H.
    PLOS ONE, 2025, 20 (01):
  • [19] Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model
    Janát-Amsbury, MM
    Yockman, JW
    Lee, M
    Kern, S
    Furgeson, DY
    Bikram, M
    Kim, SW
    MOLECULAR THERAPY, 2004, 9 (06) : 829 - 836
  • [20] Treatment of experimental breast cancer using interleukin-12 gene therapy combined with anti-vascular endothelial growth factor receptor-2 antibody
    Rakhmilevich, AL
    Hooper, AT
    Hicklin, DJ
    Sondel, PM
    MOLECULAR CANCER THERAPEUTICS, 2004, 3 (08) : 969 - 976
12345